Kodak manufactures medical equipment.

After the stock prices of sogou and Sohu skyrocketed, we saw another company with soaring stock prices, Kodak, which used to be a film giant and now wants to transform the medical field. Kodak received a $765 million government loan on July 28th, and Kodak is also using the money to prepare generic drugs, including hydroxychloroquine which President Trump said can be used to treat COVID-19, so as to reduce the dependence of the United States on foreign drugs. Trump claims that this will be a breakthrough to bring the pharmaceutical industry back to the United States, so why did the US government choose such a film giant Kodak, which seems to have nothing to do with the medical field?

The first is Kodak's own technical foundation. As a film giant, Kodak has accumulated and built infrastructure in the fields of chemistry and advanced materials for more than 65,438+000 years, which enables the company to start and operate quickly. The main functional substance of drugs is chemical molecules, and there is a certain relationship between them. U.S. officials said that once Kodak officially started construction, all the 1/4 active ingredients needed by American anti-COVID-19 drugs could be produced in Kodak. It can be seen that the US government trusts and supports Kodak.

Second, Kodak actually has pharmaceutical experience and foundation. As early as the end of last century, Kodak signed a merger agreement with Sterling, an American pharmaceutical company, and acquired Sterling, a pharmaceutical company. At that time, John Petro Petrusky, the chairman of Sterling Company, said that Kodak's growing pharmaceutical research foundation would help the two merged companies gain a leading position in the pharmaceutical industry. Although the merger of the two did not have a good result in the end: Kodak announced its withdrawal from the pharmaceutical market on 1994. Even so, the U.S. government believes that with Kodak's material chemistry foundation, it will be possible for him to achieve a grand transformation.

Third, fujifilm, the second child of the film market in the past, has achieved a successful transformation. Fuji successfully transplanted the gene of thin film technology accumulated in 85 years into the core business of medical health and high-performance materials, and became a new cross-disciplinary giant. Therefore, because of Fuji's successful experience, most American media believe that Kodak will also take this opportunity to return to Dongshan to promote the development of American pharmaceuticals and bring new hope.

In any case, there are currently more than 4 million people infected with novel coronavirus in the United States. I hope that the transformed Kodak can contribute to the pharmaceutical industry in the United States and the world, save more lives and protect more people's health.